Navigation Links
Mary-Dell Chilton von Syngenta ist Gewinnerin des Welternährungspreises 2013
Date:6/20/2013

WASHINGTON, 21. Juni 2013 /PRNewswire/ -- US-Außenminister John Kerry war heute Vorsitzender einer Zeremonie, in deren Rahmen die Syngenta-Wissenschaftlerin Mary-Dell Chilton, Ph.D., als Gewinnerin des renommierten Welternährungspreises (World Food Prize) 2013 angekündigt wurde. Der Preis ist die wichtigste internationale Auszeichnung für Einzelpersonen, die durch die verbesserte Qualität, Quantität oder Verfügbarkeit von Lebensmitteln in der Welt zur Verbesserung der menschlichen Entwicklung beigetragen haben.

Dr. Chilton und zwei andere Preisträger wurden für „revolutionäre biotechnologische Entdeckungen ausgezeichnet, die den Schlüssel zur Transformation pflanzlicher Zellen geliefert haben". Dr. Chiltons bahnbrechende, molekulare Forschung zeigte, wie ein Pflanzenbakterium als Werkzeug dazu dienen kann, Gene aus einem anderen Organismus in Pflanzenzellen einzupflanzen, die neue innovative Sorten hervorbringen können. Auf der Grundlage dieser Erkenntnisse konnte Ciba-Geigy (heute Syngenta) 1996 als erstes Unternehmen gentechnisch veränderten Mais vermarkten. Bis 2012 wurden transgene Kulturpflanzen auf mehr als 170 Millionen Hektar von über 17 Millionen Landwirten angebaut.

Mike Mack, CEO von Syngenta, erklärte: „Mary-Dell Chilton steht für das Unternehmensziel von Syngenta: bringing plant potential to life, d.h. das Potenzial der Pflanzen voll auszunutzen. Sie ist eine Pionierin der modernen Biotechnologie, die einen wichtigen Bestandteil der integrierten Lösungen darstellt, welche Landwirte benötigen, um den steigenden Anforderungen einer schnell wachsenden Weltbevölkerung hinsichtlich Lebensmitteln, Futtermitteln und Brennstoffen gerecht zu werden." 

'/>"/>
SOURCE Syngenta
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
2. Syngenta Opens Unique $72 Million Advanced Crop Lab
3. Syngenta Holds Annual General Meeting
4. Syngenta and Bayer CropScience Propose a Comprehensive Action Plan to Help Unlock EU Stalemate on Bee Health
5. Bayer CropScience and Syngenta Submit Herbicide-tolerance Soybean Trait for Approval in Various Countries
6. Syngenta Licenses Plant Sensory Systems' Technology
7. Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
8. Syngenta divests US flowers distribution and brokerage
9. Syngenta Secures EU Approval For Next Generation Fungicide
10. Pasteuria Bioscience to be Acquired by Syngenta
11. Syngenta to acquire Pasteuria Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... their offering. The markets for gene therapy ... approved gene therapy product and it is marketed in ... markets are estimated for the years 2014-2024. The estimates ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., ... in the multicenter Phase 2 clinical trial of ... treatment of recurrent subfoveal choroidal neovascularization secondary to ... a unique vascular endothelial growth factor (VEGF) receptor ... "This landmark proof-of-concept study will evaluate ...
(Date:9/2/2015)... 2, 2015 BioLight Life ... the "Company"), a firm that invests in, manages ... diagnostics, announced today that presentations highlighting its IOPtiMate™ ... delivered at the Ophthalmology Futures European Forum and ... Cataract & Refractive Surgeons ("ESCRS"), both taking place ...
(Date:9/2/2015)... ... September 02, 2015 , ... Whitehouse Laboratories ... be attending Pharma Ed Resources upcoming educational seminar and training session on Extractable ... this timely conference will provide Updates & Case Studies on the Latest Compliance ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3
... GLENWOOD, Ill., Aug. 29 Landauer, Inc. ... environmental radiation,monitoring, today announced the appointment of ... of Directors., Mr. Leatherman, currently an ... global contract negotiations, was,previously the Chief Financial ...
... Orexigen(R) Therapeutics,Inc. (Nasdaq: OREX ), a biopharmaceutical company ... obesity, today announced,that the Company will be presenting at ... the Biotech Industry Thursday, September 4, 2008, 10:00 ... UBS Global Life Sciences Conference Tuesday, September ...
... Barr Pharmaceuticals,Inc. (NYSE: BRL ) today ... approval from the U.S. Food & Drug Administration,(FDA) ... Ortho McNeil Janssen,s,Razadyne(R) (galantamine hydrobromide), 4 mg, 8 ... its generic Razadyne tablets product immediately., Barr ...
Cached Biology Technology:Landauer, Inc. Appoints Two New Members to Board of Directors 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 2Barr Receives Approval for Generic Version of Razadyne(R) Tablets 3Barr Receives Approval for Generic Version of Razadyne(R) Tablets 4Barr Receives Approval for Generic Version of Razadyne(R) Tablets 5
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/5/2015)... , August 5, 2015 Transparency ... "Facial Recognition Market - Global Industry Analysis, Size, Share, ... market for facial recognition is forecast to reach US$ ... increased demand for surveillance systems by civil and government ... of crimes and terrorist activities across the globe that ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... discovery by scientists from the Mayo Clinic in Jacksonville, ... Disease that actually removes amyloid plaquesconsidered a hallmark of ... The FASEB Journal ( http://www.fasebj.org ), is ... immune cells (microglia) are activated by the interleukin-6 protein ...
... sequence was published in 2001, scientists have been working to figure ... a desert and finding a large book in a language you ... saying. "In the case of the human genome, the ... But we don,t yet understand its language," said Morgan Giddings, Ph.D., ...
... the Oct. 15 issue of the Journal of Clinical ... exercise program may benefit obese patients with mild to moderate ... condition. Results show improvement in typical OSA symptoms ... and mood after the completion of a 16-week diet and ...
Cached Biology News:Scientists remove amyloid plaques from brains of live animals with Alzheimer's disease 2UNC scientists win $1.6 million stimulus award to accelerate decoding of human genome 2Improved diet and exercise alone unlikely to cure obstructive sleep apnea in obese patients 2
BOND ELUT MATRIX-C18, 25 mg ...
(3-[125I]iodotyrosyl26)Galanin, porcine, 370 kBq, 10 uCi. Category: IODINE LIGANDS....
Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
Homo sapiens postsynaptic protein CRIPT Antigen: Recombinant Protein...
Biology Products: